What is Linagliptin?

Category: Prescription Drugs

Most popular types: Tradjenta Trajenta Trayenta Show all

false

See also: Empagliflozin-linagliptin Linagliptin-metformin Trayenta Duo

Linagliptin is an oral antidiabetic agent use in the treatment of noninsulin dependent diabetes as an adjunct to diet and exercise as a single agent or in combination therapy with other antidiabetic agents.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 0
Moderate 4
Mild 0
None 9

Commonly reported side effects and conditions associated with Linagliptin

Side effect Patients
Dry skin 1
Insomnia 1
Itchy scalp 1
Itchy skin 1
Low blood sugar (hypoglycemia) 1

Dosages

Based on patients currently taking Linagliptin

Dosage Patients
5 mg daily 8
1 tablet(s) daily 1
2.5 mg twice daily 1
5 g daily 1
300 mg daily 1

Why patients stopped taking Linagliptin

Multiple reasons could be selected

Reason Patients
Doctor's advice 2
Did not seem to work 1
See all 2 patients who've stopped taking Linagliptin

Duration

Currently taking Linagliptin

Duration Patients
6 months - 1 year 2
2 - 5 years 10

Stopped taking Linagliptin

Duration Patients
Less than 1 month 1
5 - 10 years 1
Adherence
Adherence Evaluations
Always 9
Usually 3
Sometimes 0
Never taken as prescribed 1
Burden
Burden Evaluations
Very hard to take 0
Somewhat hard to take 1
A little hard to take 2
Not at all hard to take 10
Cost per month
Cost per month Evaluations
$200+ 0
$100-199 0
$50-99 0
$25-49 0
< $25 3
Not specified 10

What people switch to and from

Patients started taking Linagliptin after stopping:

Treatment Patients
Sitagliptin (Januvia) 2
Canagliflozin (Invokana) 1
Exenatide (Byetta) 1
Glimepiride (Amaryl) 1
Glyburide (Glynase PresTab) 1

Show all 6 treatments patients report switching from

Patients stopped taking Linagliptin and switched to:

Treatment Patients
Liraglutide (Victoza) 1
Saxagliptin (Onglyza) 1
Sitagliptin (Januvia) 1
Last updated:
There are no evaluations for Linagliptin.